Atossa Therapeutics
ATOS
#10322
Rank
C$29.63 M
Marketcap
C$3.44
Share price
-4.84%
Change (1 day)
194.57%
Change (1 year)

Earnings for Atossa Therapeutics (ATOS)

Earnings in 2025 (TTM): -C$42.34 Million

According to Atossa Therapeutics's latest financial reports the company's current earnings are N/A. In 2024 the company made an earning of -C$35.68 Million, an increase over its 2023 earnings that were of -C$42.1 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Atossa Therapeutics from 2011 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -C$42.34 Million18.67%
2024 -C$35.68 Million-15.25%
2023 -C$42.1 Million11.62%
2022 -C$37.72 Million30.84%
2021 -C$28.83 Million15.58%
2020 -C$24.94 Million3.41%
2019 -C$24.12 Million51.16%
2018 -C$15.96 Million40.41%
2017 -C$11.37 Million27.54%
2016 -C$8.91 Million-47.49%
2015 -C$16.97 Million-17.25%
2014 -C$20.51 Million35.91%
2013 -C$15.09 Million112.3%
2012 -C$7.11 Million46.53%
2011 -C$4.85 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
C$36.34 B-86,180.19%๐Ÿ‡บ๐Ÿ‡ธ USA
Quest Diagnostics
DGX
C$1.92 B-4,659.31%๐Ÿ‡บ๐Ÿ‡ธ USA
LabCorp
LH
C$1.92 B-4,656.66%๐Ÿ‡บ๐Ÿ‡ธ USA
Translate Bio
TBIO.defunct
C$58.3 M-238.11%๐Ÿ‡บ๐Ÿ‡ธ USA
NeoGenomics
NEO
-C$0.14 Billion 229.54%๐Ÿ‡บ๐Ÿ‡ธ USA
Enzo Biochem
ENZB
-C$10.97 Million-74.02%๐Ÿ‡บ๐Ÿ‡ธ USA